Those with BMI of 35 and a comorbidity could be prescribed tirzepatide and Nice says it is more effective than Wegovy
The medical treatment regulator for England has approved a second drug to combat obesity, giving patients and doctors what it says is a more effective alternative to semaglutide.
The National Institute for Health and Care Excellence (Nice) issued draft guidance on Tuesday recommending that very obese people should be prescribed tirzepatide, which is marketed in the UK as Mounjaro.
About Author
More Stories
Researchers create AI-based tool that restores age-damaged artworks in hours
Starwatch: Mars and Regulus will make for an eye-catching pair
Australia has ‘no alternative’ but to embrace AI and seek to be a world leader in the field, industry and science minister says